GOOGL
67
8
ECL
59
-3
URBN
72
2
VNO
56
-3
AMT
37
-8
SCHW
64
3
XRAY
46
2
PH
64
-2
KEY
31
-2
CINF
29
-5
UNH
52
3
DUK
49
-3
XYL
54
-2
PHM
58
-2
KR
56
11
WDC
49
-3
WY
50
-7
SJM
24
-7
FMC
41
5
DTE
49
2
GOOGL
67
8
ECL
59
-3
URBN
72
2
VNO
56
-3
AMT
37
-8
SCHW
64
3
XRAY
46
2
PH
64
-2
KEY
31
-2
CINF
29
-5
UNH
52
3
DUK
49
-3
XYL
54
-2
PHM
58
-2
KR
56
11
WDC
49
-3
WY
50
-7
SJM
24
-7
FMC
41
5
DTE
49
2
Financhill
Back

Ocular Therapeutix 10K Form

Buy
63

OCUL
Ocular Therapeutix

Last Price:
9.56
Seasonality Move:
41.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive OCUL News And Ratings

See the #1 stock for the next 7 days that we like better than OCUL

OCUL Financial Statistics

Sales & Book Value

Annual Sales: $58.44M
Cash Flow: $-36.65M
Price / Cash Flow: 0
Annual Sales: $2.25
Price / Book: 4.22

Profitability

EPS (TTM): -1.32000
Net Income (TTM): $-174.34M
Gross Margin: $53.16M
Return on Equity: -70.49%
Return on Assets: -44.46%

Ocular Therapeutix Earnings Forecast

Key Ocular Therapeutix Financial Ratios

  • The Gross Profit Margin over the past 12 years for OCUL is 90.96%.
  • The Selling, General & Administrative Expenses for OCUL have been equal to 127.46% of Gross Profit Margin.
  • The Research & Development expenses have been 104.47% of Revenue.
  • The Interest Expense is -14.04% of Operating Income.
  • The Net Earning history of OCUL is -138.14% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 6 years.

Ocular Therapeutix Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: OCUL
CUSIP: 67576A
Website: ocutx.com

Debt

Debt-to-Equity Ratio: 0.19
Current Ratio: 13.01
Quick Ratio: 12.58

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

OCUL Technical Analysis vs Fundamental Analysis

Buy
63
Ocular Therapeutix (OCUL) is a Buy

Is Ocular Therapeutix a Buy or a Sell?